Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Drug lipophilicity

Mannhold, R., Dross, K. P., Rekker, R. F. Drug lipophilicity in QSAR practice ... [Pg.82]

Kaliszan, R., Haber, P., Baczek, T., Siluk, D. Gradient HPLG in the determination of drug lipophilicity and acidity. Pure Appl. Chem. 2001, 73, 1465-1475. [Pg.353]

Rekker, R. F., Mannhold, R. Calculation of Drug Lipophilicity. The Hydrophobic Fragmental Constant Approach, VCH, Weinheim, 1992. [Pg.377]

FIGURE 4. Correlation between the relative inhibitory potencies of various drugs at high- and low-affinity [ H]MDA binding and between drug lipophilicities and inhibition potencies of [ H]MDA binding... [Pg.230]

Figure 7 Influence of drug lipophilicity (log PC) on the ratio of corneal to conjunctival permeability coefficients of beta-blockers. (From Ref. 158.)... Figure 7 Influence of drug lipophilicity (log PC) on the ratio of corneal to conjunctival permeability coefficients of beta-blockers. (From Ref. 158.)...
Camenisch, G., Alsenz, J., van de Waterbeemd, H., Folkers, G., Estimation of permeability by passive diffusion through Caco-2 cell mono-layers using the drugs lipophilicity and molecular weight, Eur. J. Pharm. Sci. 1998, 6, 313-319. [Pg.70]

D. J., Roffey, S. J., Jezequel, S. G., Abbott, N. J., The effect of drug lipophilicity on P-glycoprotein-mediated colchicine efflux at the blood-brain barrier, Int. J. Clin. Pharmacol. Ther. 1998, 36, 84-86. [Pg.489]

The affinity of the various stabilized dipeptidyl prodrugs to hPepTl in Caco-2 cells was also investigated [42, 43, 50]. In the case of the D-Glu-Ala ester-linked benzyl alcohols, an improved hPepTl affinity with increasing drug lipophilicity was observed [50], Furthermore, these model prodrugs are transported trans-epithelially across Caco-2 cells by virtue of a hPepTl-mediated process [50]. Preliminary hPepTl affinity studies made on Asp-Sar- and Glu-Sar-based (model)-... [Pg.537]

Dressman et al. [13] developed a dimensionless absorption potential (AP) model based on the concept that the fraction of dose absorbed, assuming negligible luminal instability and first-pass metabolism, is a function of drug lipophilicity (log P0/w), solubility (Sw), and dose (D), as defined in Eq. 2.7. [Pg.39]

The coexistence of lipid and water solubility in the same molecule is essential for the action of a local anaesthetic drug. Lipophilicity permits the migration of drug across the phospholipid membrane of the nerve cell hydrophilicity is essential for the ionisation of the drug within the nerve. It follows that lipid and water solubility are the external and internal facilitators of local anaesthetic action in the nerve cell. Both within and without the nerve cell the unionised and ionised forms coexist in dynamic equilibrium. Outside the nerve, the active species is the unionised tertiary amine form. Conversely, inside the cell the ionised form predominates. The lower intracellular pH induces a shift in the equilibrium in favour of ionisation (Figure 5.5). [Pg.93]

R. F. Rekker, R. Mannhold, Calculation of drug lipophilicity the hydrophobic fragmentat constant approach, VCH, Weinheim, Germany, 1992. [Pg.209]

Noguchi, T., W.N. Charman, and V.J. Stella. 1985. The effect of drug lipophilicity and lipid vehicles on the lymphatic absorption of various testosterone esters. Int J Pharm 24 173. [Pg.130]

Unionized form of the drug=lipophilic membrane transport ... [Pg.20]

The pKa is an important physicochemical parameter. The analyte pKa values are especially important in regard to pharmacokinetics (ADME—absorption, distribution, metabolism, excretion) of xenobiotics since the pKa affects the apparent drug lipophilicity [59]. Potentiometric titrations and spectrophome-tric analysis can be used for pKa determination however, if the compound is not pure, is poorly soluble in water, and/or does not have a significant UV chromophore and is in limited quantity, its determination may prove to be challenging. [Pg.179]


See other pages where Drug lipophilicity is mentioned: [Pg.618]    [Pg.499]    [Pg.742]    [Pg.359]    [Pg.375]    [Pg.504]    [Pg.356]    [Pg.69]    [Pg.38]    [Pg.310]    [Pg.477]    [Pg.230]    [Pg.14]    [Pg.530]    [Pg.109]    [Pg.223]    [Pg.594]    [Pg.14]    [Pg.65]    [Pg.118]    [Pg.222]    [Pg.61]    [Pg.597]    [Pg.1237]    [Pg.250]    [Pg.201]   
See also in sourсe #XX -- [ Pg.78 , Pg.79 , Pg.80 , Pg.134 , Pg.197 ]




SEARCH



Cyclosporine Lipophilic drugs)

Delivery of Lipophilic Drugs from LLC Systems

Drug design lipophilic compounds

Drug molecules lipophilicity

Gastrointestinal lipophilic drug absorption

Gastrointestinal lipophilic drug absorption barriers

Gastrointestinal lipophilic drug absorption enhancement

Gastrointestinal lipophilic drug absorption mechanisms

Gastrointestinal lipophilic drug absorption solubility

Gastrointestinal lipophilic drug absorption solutions

Gastrointestinal lipophilic drug absorption systems

Lipophilic compounds, transdermal drug

Lipophilic drug absorption

Lipophilic drug absorption activity

Lipophilic drug absorption approach

Lipophilic drug absorption barriers

Lipophilic drug absorption emulsions

Lipophilic drug absorption enhanced gastrointestinal

Lipophilic drug absorption enhancing

Lipophilic drug absorption enterocyte barriers

Lipophilic drug absorption lipid-based formulations

Lipophilic drug absorption lymphatic transport

Lipophilic drug absorption mechanisms

Lipophilic drug absorption prodrug approach

Lipophilic drug absorption self-emulsifying systems

Lipophilic drug absorption solubility

Lipophilic drug absorption systems

Lipophilic drug absorption water-soluble prodrug

Lipophilic drug elimination

Lipophilic drugs

Lipophilic drugs

Lipophilic drugs bioavailability

Lipophilic drugs corneal epithelium penetration

Lipophilic drugs disposition

Lipophilic drugs dissolution

Lipophilic drugs emulsions

Lipophilic drugs enterocyte

Lipophilic drugs incorporated

Lipophilic drugs intestinal lymph

Lipophilic drugs lipid solutions

Lipophilic drugs liposome formulations

Lipophilic drugs lymphatic transport

Lipophilic drugs medium-chain triglycerides

Lipophilic steroidal drug

Lipophilicity antitumor drugs

Lipophilicity of drug

Lipophilicity of the drug

Lipoproteins Lipids Lipophilic drugs)

Oral epithelium lipophilic drugs

Role of Lipophilicity in Drug Clearance

© 2024 chempedia.info